NCT01709175

Strength Training Study for Survivors of Breast and Gynecologic Cancer

The Effect of Resistance Exercise Frequency in Breast and Gynecologic Cancer Survivors

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Nova Scotia Health Authority · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare once-a-week vs. twice-a-week strength training in survivors of breast and gynecologic cancer to determine which is the optimal exercise prescription.

Detailed description

As a result of cancer and its treatment, survivors of breast and gynecologic cancer are reported to have deficits in both physical and psycho-social health. In cancer survivors exercise has been shown to improve fitness, increase bone density and lean body mass, enhance self-esteem, and reduce fatigue. These changes have a positive effect on the survivor's physical functioning and quality of life. However, there are few studies which have examined the effects of strength training or studies aimed at determining optimal exercise prescription in this population. Therefore, the purpose of this study is to compare two strength training prescriptions (once-a-week vs. twice-a-week strength training) to determine which prescription (if any) results in greater benefit for survivors. It is hoped that the results of this study will lead to a better understanding of how strength training improves the health of survivors and will help inform future exercise guidelines for this population.

Conditions

• Breast Cancer
• Gynecologic Cancer
• Ovarian Cancer
• Uterine Cancer
• Cervical Cancer

Interventions

Type	Name	Description
BEHAVIORAL	Strength Training	This is a 13 week strength training program. Sessions will be supervised by a Certified Exercise Physiologist in a group setting.

Timeline

• Start date: 2012-11-01
• Primary completion: 2015-01-01
• Completion: 2015-01-01
• First posted: 2012-10-18
• Last updated: 2015-06-08

Locations

1 site across 1 country: Canada